• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

How to Think About Stocks as President Trump Announces Military Strikes on Syria
POLITICS

What to expect from Trump's speech on drug prices on Friday

  • By Bill Meagher
  • May 10, 2018 2:43 PM EDT
These Are the Biggest Winners and Losers in Activist Investing This Year
MERGERS AND ACQUISITIONS

These Are the Biggest Winners and Losers in Activist Investing This Year

  • By Ronald Orol
  • Dec 11, 2017 7:04 AM EST
Here's How You Can Easily Tell Golf Addict President Trump Absolutely Loves the Masters
REGULATION

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

  • By William McConnell
  • Aug 11, 2017 1:20 PM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: FibroGen Leaps on Results for Pulmonary Fibrosis Study

  • By Armie Margaret Lee
  • Aug 8, 2017 9:29 AM EDT
Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
HEALTH

Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER

  • By Melissa Angell
  • Jun 9, 2017 5:20 PM EDT
Young Guns of Activism Join Boards at AIG, SunOpta and DepoMed
MERGERS AND ACQUISITIONS

The Young Guns of Activism

  • By Ronald Orol
  • May 23, 2017 3:40 PM EDT
Depomed Focuses on Flagship Drug Rather Than M&A: CEO
MERGERS AND ACQUISITIONS

Beefing Up Nucynta Franchise, Not M&A Is Depomed's Focus Now

  • By William McConnell
  • May 10, 2017 7:38 PM EDT
Mylan's Shares Rise Despite FTC Investigation
STOCKS

Biotech Movers: Depomed Shares Tank After Earnings Get Even Worse

  • By William McConnell
  • May 10, 2017 9:34 AM EDT
Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More
STOCKS

Analysts' Actions -- Allergan, Coach, General Dynamics, Occidental and More

  • By TheStreet Staff
  • May 10, 2017 9:29 AM EDT
Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector
POLITICS

Opioid Makers Fall After FDA Pick Gottlieb Says America's Drug Addiction Is Out of Control

  • By William McConnell
  • Apr 5, 2017 5:00 PM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: Sage Therapeutics, Depomed, NantKwest

  • By Armie Margaret Lee
  • Mar 31, 2017 9:28 AM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: Vertex, Sangamo, Depomed

  • By Armie Margaret Lee
  • Mar 29, 2017 9:31 AM EDT
Senator McCaskill Launching Investigation Into Opioid Drugmakers
MERGERS AND ACQUISITIONS

Depomed switches out CEO and board in making peace with activist Starboard

  • By Bill Meagher
  • Mar 29, 2017 7:01 AM EDT
Senator McCaskill Launching Investigation Into Opioid Drugmakers
STOCKS

Senator McCaskill Launching Investigation Into Opioid Drugmakers

  • By Amanda Schiavo
  • Mar 28, 2017 1:30 PM EDT
Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group
MERGERS AND ACQUISITIONS

A Deal is Imminent For Depomed, CFO Says

  • By Alicia McElhaney
  • Mar 23, 2017 7:07 PM EDT
Argos Plummets 72%, Leads Biotech Movers
STOCKS

Biotech movers: Argos plummets 72%

  • By Alicia McElhaney
  • Feb 22, 2017 8:52 AM EST
Drug Giant Eli Lilly Wants to Save Money So it Brought in These New Bigwigs
STOCKS

Pain med company Depomed reports adjusted earnings of $1.15 per share

  • By Bill Meagher
  • Feb 21, 2017 8:34 PM EST
Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
MERGERS AND ACQUISITIONS

Perrigo settles with activist investor Starboard

  • By Armie Margaret Lee
  • Feb 7, 2017 1:39 PM EST
Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix
STOCKS

Biotech stock mailbag: Trump, Aurinia, Immunomedics, Cellceutix

  • By Adam Feuerstein
  • Jan 27, 2017 8:13 AM EST
Dow Industrials Hit 20,000 for the First Time in History
FUTURES

Dow's march to 20,000 hits another snag as crude settles at two-week low

  • By Keris Alison Lahiff
  • Jan 3, 2017 4:06 PM EST
Stocks Mixed Again as Dow Declines but Nasdaq Remains on Track for Record Close
FUTURES

Dow's attempt at 20,000 fades as crude reverses course

  • By Keris Alison Lahiff
  • Jan 3, 2017 3:09 PM EST
Stocks Ease Off Highs as Dow 20,000 Remains a Challenge
FUTURES

Stocks ease off highs as Dow 20,000 remains a challenge

  • By Keris Alison Lahiff
  • Jan 3, 2017 11:07 AM EST
5 Things You Must Know Before the Market Opens Friday
FUTURES

Stock futures rise ahead of first trading day of 2017

  • By Keris Alison Lahiff
  • Jan 3, 2017 8:42 AM EST
Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
MERGERS AND ACQUISITIONS

Ranking the activists for proxy season 2016

  • By Ronald Orol
  • Dec 1, 2016 8:02 AM EST
Cerner Stock Jumps, Leerink Raises Price Target
MERGERS AND ACQUISITIONS

Depomed reports dip in earnings, reduces revenue guidance

  • By Bill Meagher
  • Nov 8, 2016 11:54 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.